Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways

被引:50
|
作者
Maines, Mahin D. [1 ]
机构
[1] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA
关键词
D O I
10.1089/ars.2007.1805
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biliverdin reductase (BVR) was characterized some 25 years ago as a unique dual-cofactor/pH-dependent enzyme that catalyzes the reduction of biliverdin-IXa. Our knowledge of functions of BVR has increased enormously in recent years. hBVR functions in the IR/IGF-1-controlled regulation of the MAPK and PI3K cascades that are linked by the PKC enzymes. The first of the two culminates in the activation of transcription factors for oxidative stress-responsive genes, including ho-1, where BVR functions as both a bZip (basic leucine zipper) transcription factor and a kinase. The second pathway amplifies the insulin/growthfactor signal for protein/DNA synthesis and glucose transport downstream of PI3K. hBVR is a transactivator of PKC-beta II, and thus an integral component of the "activation loop" linking MAPK, PKC-beta II, and PI3K to insulin/growth-factor signaling. The emergence of biliverdin and bilirubin as a newly defined category of modulators of cell signaling and kinase activity further underscores the critical input of hBVR in the response of intracellular pathways into the external environment. Structural features of BVR and recent findings relevant to its function in cell-signaling pathways are reviewed here and are intended to complement a recent commentary on the role of BVR in linking heme metabolism and cell signaling.
引用
收藏
页码:2187 / 2195
页数:9
相关论文
共 50 条
  • [21] Opioid-induced cardioprotection involves cross-talk between KATP channels and the phosphatidylinositol-3 kinase (PI3k) pathways
    Gross, ER
    Hsu, AK
    Gross, GJ
    FASEB JOURNAL, 2005, 19 (05): : A1563 - A1563
  • [22] Kv4.2 is a locus for PKC and ERK/MAPK cross-talk
    Schrader, Laura A.
    Ren, Yajun
    Cheng, Feng
    Bui, Dui
    Sweatt, J. David
    Anderson, Anne E.
    BIOCHEMICAL JOURNAL, 2009, 417 : 705 - 715
  • [23] The proto-oncogene c-src is involved in primordial follicle activation through the PI3K, PKC and MAPK signaling pathways
    Du, Xiao-Yu
    Huang, Jian
    Xu, Liang-Quan
    Tang, Dan-Feng
    Wu, Lei
    Zhang, Li-Xia
    Pan, Xiao-Ling
    Chen, Wei-Yun
    Zheng, Li-Ping
    Zheng, Yue-Hui
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2012, 10
  • [24] PI3K/mTOR Signaling Pathways in Medulloblastoma
    Mohan, Avinash L.
    Friedman, Marissa D.
    Ormond, D. Ryan
    Tobias, Michael
    Murali, Raj
    Jhanwar-Uniyal, Meena
    ANTICANCER RESEARCH, 2012, 32 (08) : 3141 - 3146
  • [25] Cross-Talk Between STAT3 and MAPK Signaling in Pancreatic Cancer
    Nagathihalli, N.
    Beesetty, Y.
    Shi, C.
    Merchant, N.
    PANCREAS, 2012, 41 (08) : 1389 - 1389
  • [26] Cross-talk between JNK/SAPK and ERK/MAPK pathways
    Shen, YH
    Godlewski, J
    Zhu, J
    Sathyanarayana, P
    Leaner, V
    Birrer, MJ
    Rana, A
    Tzivion, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (29) : 26715 - 26721
  • [27] Exploring the cross-talk between p38 MAPK and canonical Wnt signaling pathways
    Flick, Lisa M.
    Florczyk, Stephen J.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [28] Knockout of PKCα enhances insulin signaling through PI3K
    Letiges, M
    Plomann, M
    Standaert, ML
    Bandyopadhyay, G
    Sajan, MP
    Kanoh, Y
    Farese, RV
    MOLECULAR ENDOCRINOLOGY, 2002, 16 (04) : 847 - 858
  • [29] Pathogenetic PI3K and MAPK pathways in Alzheimer neurofibrillary degeneration
    Pei, JJ
    An, WL
    Winblad, B
    FASEB JOURNAL, 2005, 19 (04): : A505 - A505
  • [30] Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells
    Hong, Zhong
    Wang, Zhaohong
    Zhou, Bin
    Wang, Jisheng
    Tong, Hongfei
    Liao, Yi
    Zheng, Peng
    Jamshed, Muhammad Babar
    Zhang, Qiyu
    Chen, Hui
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (03) : 783 - 793